Table 4.
Interaction between blood pressure and visceral adiposity accounting for the risk of arterial stiffening and albuminuria in patients with type 2 diabetes
| ba-PWV | UAE | |||
|---|---|---|---|---|
| Standardized β | p values | Standardized β | p values | |
| SBP × VFA | −0.008 | 0.916 | 0.172 | 0.040 |
| Systolic blood pressure | 0.177 | <0.001 | 0.171 | 0.001 |
| Visceral fat area | 0.149 | 0.149 | −0.060 | 0.471 |
| Age | 0.430 | <0.001 | NA | |
| Body mass index | −0.299 | 0.001 | NA | |
| eGFR | −0.146 | 0.008 | NA | |
| Calcium channel blocker | 0.109 | 0.029 | NA | |
| HbA1c | NA | −0.138 | 0.009 | |
| CV-RR | NA | 0.148 | 0.005 | |
| Gender (male versus female) | NA | 0.130 | 0.015 | |
| Angiotensin receptor blocker | NA | 0.114 | 0.030 | |
| Insulin | NA | 0.109 | 0.035 | |
ba-PWV brachial-ankle pulse wave velocity, CV-RR Coefficient of variation of RR intervals, eGFR estimated glomerular filtration rate, SBP systolic blood pressure, UAE urinary albumin excretion, VFA visceral fat area